RSPO4 and Hepatic fibrosis: In conclusion, this study revealed that RSPO4 gene knockout with the CRISPR system relieves the liver fibrogenesis in rats, and restores dysbiotic gut microbiota related to liver fibrosis to an equilibrium status similar to healthy rats.